In this study, researchers are testing a new treatment called **SELUTION SLR™ 018 DEB** for people with blockages in certain leg arteries. They want to see if it’s better than the current method, which uses a plain balloon to open arteries. This study is for people with **Peripheral Arterial Disease (PAD)**, a condition where blood flow is reduced in the arteries, specifically in the **superficial femoral artery (SFA)** and **proximal popliteal artery (PPA)**.
The study will include 300 people who will be split into two groups: one group will receive the new treatment, and the other will get the regular treatment. A smaller group of 20 people will participate in a side study to understand how the drug acts in the body.
**Key Points**:
- **Participation**: Up to 300 subjects, with a special sub-study for 20 subjects.
- **Locations**: Conducted at up to 60 sites in the US, Europe, and Asia.
- **Involvement**: Regular follow-ups and evaluations are required.
This study is important for those with PAD, looking for potentially better treatments. Participants need to follow specific guidelines and consent to the procedures.
How understandable was the trial content above?
Hard to understand
Easy to understand